Guidance Document - American Association of Tissue Banks

More documents

Recommendations

Info

Section III.Donor Screening and Donor TestingPage 16 of 44
III. DONOR SCREENING & DONOR TESTINGQ1. What expectations are there for ensuring that the collection of donoreligibility information by a recovery agency meets the processors’expectations (since they are performing a function on behalf of a tissueprocessor or the entity determining suitability)?A1. Expectations would include the information that is assigned or implied (usuallylisted as “responsibilities” of each party) via a contractual agreement between thetwo entities. Compliance, however, would also include establishment andmaintenance of a quality program by both entities, which includes, but is not limitedto, periodic internal/external auditing, procedures describing proper informationsharing, evidence of training/educational programs, and assurance of competencyof personnel who collect information that will be used by others to determine donoreligibility.Q2. How would the contracting establishment provide proof that work beingdone on their behalf is performed in compliance with CGTPs?A2. The contracting bank should verify the work performed on their behalf using anumber of quality program operations. Documented review of each donor recordshall be performed as well as documentation of significant errors found whichshould be tracked and trended according to written SOPs. Performance indicatorsare established by the tissue bank and maintained as part of the quality program.Scheduled, routine, and unscheduled (when indicated) quality audits should beperformed by the contracting bank. Each organization should possess currentregistrations, certifications, and accreditations held by those with whom theycontract (e.g. FDA, ISO, CLIA, CMS, AATB, EBAA, AABB, AOPO, etc.)Q3. How does the tissue bank that contracts with another establishment toperform another step in the manufacture of tissues ensure the contractedbank’s compliance with CGTPs?A3. This could be achieved through periodic auditing in conjunction with recognition ofaccreditations held (e.g. CLIA, CMS, AATB, EBAA, etc.) from the contractedestablishment. Audit/inspection content should, at a minimum, contain a review forcompliance to all requirements of 21 CFR 1271 applicable to the operations thatthe establishment performs.Q4. Are testing laboratories included in the list of “manufacturers” of tissues andhow would a tissue bank ensure compliance of such establishments?A4. Yes, laboratories that perform tissue donor testing that includes required infectiousdisease screening tests (i.e., HIV, HBV, HCV, syphilis, HTLV, CMV) that are usedto determine tissue donor eligibility would need to comply with applicable CGTPs.Testing labs that do not register and list as required will be subject to FDAPage 17 of 44
Page 5 and 6: purpose of this Guidance Document i
Page 8 and 9: periodic reviews of the performance
Page 12 and 13: Q10. Does the sterilizer that is us
Page 14 and 15: eagents meet established specificat
Page 18 and 19: enforcement. If a tissue establishm
Page 20 and 21: contractor has necessary elements o
Page 22 and 23: A17. No. Tissue processing-related
Page 24 and 25: IV. PACKAGINGQ1. Does the immediate
Page 26 and 27: V. LABELINGQ1. Given that new infec
Page 28: Q11. Must labeling operations, such
Page 31 and 32: distinct identification code in you
Page 33 and 34: Section VI.DistributionPage 33 of 4
Page 35 and 36: Q5. Is shipping container qualifica
Page 37 and 38: esponsible for notifying the tissue
Page 39 and 40: Section VII.ProcessingPage 39 of 44
Page 41 and 42: • Surface Monitoring - taking int
Page 43 and 44: Section VIII.StoragePage 43 of 44

Guidance Document - American Association of Tissue Banks

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?